GENMAB A/S |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,737 DKK | +1.65% |
|
-4.70% | -19.89% |
| 28/06 | Would you like some more inflation? |  |
| 28/06 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
Quotes 5-day view
Delayed Quote London S.E.| 27/06/2024 | 28/06/2024 | 01/07/2024 | 02/07/2024 | 03/07/2024 | |
|---|---|---|---|---|---|
| Last | 1789.8333 kr | 1761.1191 kr | 1738.6 kr | 1712 kr | 1,716 kr |
| Volume | 71 470 | 3 974 | 1 451 | 3 069 | 0 |
| Change | -0.60% | -1.60% | -1.28% | -1.53% | +1.65% |
| Opening | 1,787.25 | 1,781.25 | 1,751.75 | 1,726.25 | 1,716 |
| High | 1,805.50 | 1,791.00 | 1,753.00 | 1,727.00 | 1,716 |
| Low | 1,776.50 | 1,737.00 | 1,724.50 | 1,696.50 | 1,716 |
Performance
| 1 day | +1.65% | ||
| 1 week | -4.70% | ||
| Current month | -2.56% | ||
| 1 month | -12.16% | ||
| 3 months | -16.24% | ||
| 6 months | -19.76% | ||
| Current year | -19.89% | ||
| 1 year | -33.31% | ||
| 3 years | -33.93% | ||
| 5 years | +40.02% | ||
| 10 years | +653.29% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
5 335
Daily volume ratio
0.00
Avg. Volume 20 sessions DKK
9 265 561.25
Avg. Volume 20 sessions USD
1 341 736.66
Record volume 1
2 505 407
Record volume 2
618 614
Record volume 3
450 000
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (DKK)
108 490 205 043
Capitalization (USD)
15 710 358 102
Net sales (DKK)
16 474 000 000
Net sales (USD)
2 385 583 466
Number of employees
2 286
Sales / Employee (DKK)
7 206 474
Sales / Employee (USD)
1 043 562
Free-Float
98.51 %
Free-Float capitalization (DKK)
111 369 773 611
Free-Float capitalization (USD)
16 127 345 547
Average Daily Capital Traded
0.01%
Highs and lows
1 week
1 696.50
1 805.50
1 month
1 696.501 976.00
Current year
1 696.502 219.00
1 year
1 696.502 814.00
3 years
1 696.503 325.00
5 years
1 118.503 325.00
10 years
207.753 325.00
Indicators
Moving average 5 days
1 750.25
Moving average 20 days
1 836.04
Moving average 50 days
1 928.80
Moving average 100 days
1 973.31
Price spread / (MMA5)
+0.78%
Price spread / (MMA20)
+5.72%
Price spread / (MMA50)
+11.06%
Price spread / (MMA100)
+13.62%
STIM
RSI 9 days
16.50
RSI 14 days
22.33
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.65% | -4.70% | -19.89% | -33.31% | 15.71B | ||
| -0.47% | -0.59% | +15.81% | +35.58% | 122B | ||
| -1.25% | -3.50% | +17.47% | +43.68% | 113B | ||
| -2.04% | -4.10% | +17.18% | +15.20% | 26.22B | ||
| +2.98% | -2.14% | -23.48% | -25.10% | 19.01B | ||
| +2.45% | +0.93% | -18.06% | -18.28% | 15.22B | ||
| -0.96% | -5.43% | -47.37% | -38.55% | 14.72B | ||
| -0.58% | -1.96% | +59.54% | +35.55% | 14.58B | ||
| +0.83% | +2.07% | +5.22% | +46.74% | 13.84B | ||
| -1.35% | -7.18% | +106.60% | +208.55% | 10.4B | ||
| -1.31% | +2.29% | +139.42% | +266.19% | 9.15B | ||
| +0.31% | +2.22% | +22.16% | +55.89% | 8.27B | ||
| +2.13% | +0.87% | -24.75% | -34.24% | 8.16B | ||
| -1.11% | +2.95% | +8.42% | +54.94% | 7.82B | ||
| +0.23% | +5.95% | -2.64% | +31.26% | 7.51B | ||
| +0.37% | -0.89% | +39.43% | +39.74% | 6.53B | ||
| Average | +0.10% | -1.42% | +18.44% | +42.74% | ||
| Weighted average by Cap. | -0.42% | -1.64% | +15.12% | +35.68% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -20.08% | ||
| 2023 | -27.88% | ||
| 2022 | +13.08% | ||
| 2021 | +8.53% | ||
| 2020 | +62.53% | ||
| 2019 | +40.54% | ||
| 2018 | +2.07% | ||
| 2017 | -11.51% | ||
| 2016 | +27.85% | ||
| 2015 | +158.96% | ||
| 2014 | +61.41% | ||
| 2013 | +174.38% | ||
| 2012 | +116.04% | ||
| 2011 | -43.51% | ||
| 2010 | -20.30% | ||
| 2009 | -65.07% | ||
| 2008 | -24.30% | ||
| 2007 | -9.39% |
- Stock Market
- Equities
- GMAB Stock
- 0MGB Stock
- Quotes Genmab A/S
